Are We Missing a Critical Window for Preventing Diarrheal Deaths in Children?

By Kate Pfizenmaier / Global WACh

Death from diarrheal disease is entirely preventable yet it remains the second leading cause of death worldwide in children under five. When a child arrives at a clinic with severe diarrhea in a low-income country, say Kenya, what dictates the treatment they get? How do we define the severity of their condition and when do we assume it could be life threatening? 

Department Part of Major Study to Test Antibiotics as a Treatment for Diarrheal Disease in High-Risk Children in Low Resource Settings

By Amelia Vader

Researchers at the University of Washington and Kenya Medical Research Institute are working to determine if antibiotics could help save thousands of children from dying of diarrheal disease thanks to a four-year $2.5 million grant from the World Health Organization.

The Antibiotics for Children with Severe Diarrhea (ABCD) Trial is the largest clinical trial addressing diarrhea management to date; and it will not only answer the question of the potential benefits of antibiotics it will also address any potential harm, such as antibiotic resistance.